Nancy J. Wysenski
2010
In 2010, Nancy J. Wysenski earned a total compensation of $1.5M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 85% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $426,300 |
|---|---|
| Option Awards | $611,693 |
| Salary | $474,192 |
| Other | $35,097 |
| Total | $1,547,282 |
Wysenski received $611.7K in option awards, accounting for 40% of the total pay in 2010.
Wysenski also received $426.3K in non-equity incentive plan, $474.2K in salary and $35.1K in other compensation.
Rankings
In 2010, Nancy J. Wysenski's compensation ranked 3,858th out of 10,439 executives tracked by ExecPay. In other words, Wysenski earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,858 out of 10,439 | 63rd |
Division Manufacturing | 1,354 out of 3,838 | 65th |
Major group Chemicals And Allied Products | 267 out of 921 | 71st |
Industry group Drugs | 144 out of 680 | 79th |
Industry Pharmaceutical Preparations | 111 out of 481 | 77th |
Source: SEC filing on April 10, 2012.
Wysenski's colleagues
We found five more compensation records of executives who worked with Nancy J. Wysenski at Vertex Pharmaceuticals in 2010.
2010
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2010
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2010
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2010
Kenneth Boger
Vertex Pharmaceuticals
Chief Legal Officer
2010
Amit Sachdev
Vertex Pharmaceuticals